Eindhoven, The Netherlands — CytoSMART Technologies, an Axion Bio company, announced the launch of the CytoSMART Omni FL, a next-generation live-cell imaging analysis system incorporating red and green fluorescence channels into its signature CytoSMART Omni product line for the first time. The advance reflects the company’s ongoing commitment to provide high-quality, accessible live-cell imaging to every cell biology lab and offers an innovative platform for researchers in stem cell biology, immuno-oncology, virology, toxicology, neurology, and other fields.
Joffry Maltha, CEO at CytoSMART Technologies stated, "We are very excited to launch a fluorescence version of the popular brightfield live-cell imager CytoSMART Omni. The new CytoSMART Omni FL brings research to another level and allows scientists to gain greater insight into their experiments while reducing the amount of time spent on manual labor. This advancement represents the next big step in our continued product line innovation strategy designed to accelerate scientific discovery and drug development."
Live-cell fluorescence microscopy is a powerful tool with broad applications in biological research. Using fluorescent tags, dyes, and other methods to label and examine molecules of interest, imaging provides a critical window into the physiology and function of cells over time and enables the creation of high-quality time-lapse videos to track complex cellular processes. Featuring an innovative design that operates efficiently in a cell culture incubator, universal compatibility with any transparent culture vessel, and AI-driven analysis with user-friendly data storage solutions, the low-maintenance CytoSMART Omni FL overcomes the limitations of other imaging platforms and allows for plug-and-play experimentation right out of the box. Applications of live-cell fluorescence imaging include evaluating cell health and viability, assessing wound healing and colony formation, studying transfection efficiency, and investigating complex culture models such as co-cultures and 3D organoids.
According to Axion President and CEO Tom O’Brien, "CytoSMART has reimagined the microscope, engineering powerful imaging systems that fit comfortably in a standard incubator. While other imaging systems may miss small changes or rare cells or interest, the CytoSMART Omni continuously captures the whole culture surface for a more complete picture. The launch of the Omni FL is another step forward in our mission to provide customers with high-quality instruments and powerful software that rapidly advance live-cell research, as well as cell and gene therapy development."